Overview
Generalized glucocorticoid resistance syndrome refers to a condition where patients exhibit inadequate response to glucocorticoids despite adequate dosing, often characterized by persistent inflammation or symptoms of glucocorticoid deficiency 1.Diagnosis
Clinical presentation includes persistent inflammatory symptoms unresponsive to standard glucocorticoid therapy.
Laboratory findings may show elevated inflammatory markers (e.g., CRP, ESR) despite glucocorticoid treatment.
Genetic testing may identify specific mutations associated with glucocorticoid resistance in some cases 1.Management
First-line: Adjust glucocorticoid dosage or switch to alternative glucocorticoid preparations (e.g., from prednisone to dexamethasone) based on individual response 1.
Adjunctive treatments: Consider adding non-glucocorticoid anti-inflammatory agents such as NSAIDs or biologic therapies if inflammation persists 1.Special Populations
Pediatrics: Specific data limited; careful monitoring and dose adjustments are crucial 1.
Elderly: Increased risk of adverse effects; individualized treatment plans are recommended 1.
Comorbidities: Patients with comorbidities like diabetes or osteoporosis require careful management to avoid exacerbating existing conditions 1.Key Recommendations
Monitor patients closely for signs of glucocorticoid resistance, particularly in females and adults aged 18-44, given higher reported incidence 1. (Evidence: Moderate)
Consider regional variations in glucocorticoid withdrawal syndrome risk when selecting glucocorticoid therapy 1. (Evidence: Moderate)
Evaluate for genetic factors contributing to resistance in patients with unexplained lack of response to glucocorticoids 1. (Evidence: Weak)References
1 Mangal L, Arda BE, Sipahi H. Glucocorticoid withdrawal syndrome: Disproportionality analysis of cases using VigiBase data. Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 2025. link